Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Rhabdomyolysis Etiology
    ABSTRACT & COMMENTARY

    Rhabdomyolysis Etiology

    January 1, 2021
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Pharmacology Watch: Statins and the Incidence of Rhabdomyolysis

    A Population-Based View into the Incidence and Etiology of Papilledema

    Autoimmune Antibodies in Patients with Epilepsy of Unknown Etiology

    Related Products

    Autoimmune Antibodies in Patients with Epilepsy of Unknown Etiology

    Alzheimer’s Disease: What the Primary Care Physician Needs to Know

    Keywords

    Neurology

    Genetics

    kidney

    neuromuscular

    rhabdomyolysis

    By Michael Rubin, MD

    Professor of Clinical Neurology, Weill Cornell Medical College

    Dr. Rubin reports he is a consultant for Merck Sharp & Dohme Corp.

    SYNOPSIS: Rhabdomyolysis can be a life-threatening condition that often triggers a neurology consultation during an investigation for cause. However, in this recent study, the majority of cases (79%) were triggered by external, non-neuromuscular causes, and the others, although suspicious for an intrinsic muscular or genetic cause, rarely had a specific diagnosis confirmed.

    SOURCE: Kruijt N, van den Bersselaar LR, Kamsteeg EJ, et al. The etiology of rhabdomyolysis: An interaction between genetic susceptibility and external triggers. Euro J Neurol 2020; Sep 25. doi:10.1111/ene.14553. [Online ahead of print].

    Muscle pain, weakness, and dark urine comprise the triad of symptoms of rhabdomyolysis, a medical emergency characterized by muscle necrosis and the release of intracellular muscle components into the circulation, including creatine kinase (CK), aldolase, myoglobin, lactic dehydrogenase, and electrolytes. Patients may be asymptomatic, demonstrating only elevations in serum muscle enzymes, or may experience life-threatening disease, including acute kidney injury and renal failure. External environmental triggers are central to initiating rhabdomyolysis and predisposing genetic factors may increase susceptibility. What are these triggers and genetic factors?

    A retrospective review of all patients admitted to the Radboud University Medical Center, Nijmegen, The Netherlands, between January 2014 and January 2019 was undertaken. Inclusion criteria for study selection required a discharge diagnosis of rhabdomyolysis, and a CK > 2,000 IU/L, since a normal CK may run as high as 1,001 IU/L. Patients referred to the neurology department for evaluation of rhabdomyolysis, following prior hospitalization, also were included. For primary trigger analysis, presumed triggers were divided into neuromuscular and non-neuromuscular causes, with the latter further subdivided into ischemic, traumatic, long-lie (on the ground for more than an hour post-fall), endocrine, convulsions, post-operative, acquired myopathic, and other. Patients were considered to have a presumed neuromuscular disorder if they had muscular dystrophy; congenital, metabolic, mitochondrial or other inherited myopathy; neuroleptic malignant syndrome; serotonin syndrome; or heat-related illness (heat stroke, heat exhaustion, or heat cramps).

    In a secondary analysis, the investigators extracted data regarding genetic testing, including whole-exome sequencing, and for genes in which variants were found, comparing them to genes previously reported as associated with rhabdomyolysis. Statistical analysis included the chi-squared test, Fisher’s exact test, and the Mann–Whitney U-test.

    Among 1,302 patient records selected, 934 (72%) were men, 368 (28%) were women, median age was 53 years (range 0 to 98 years), and median peak CK was 4,423. Men predominated in all categories except for the long-lie group. Non-neuromuscular causes were responsible in 1,025 (79%) patients, most commonly resulting from ischemia/anoxia (42%), followed by trauma (20%). Genetic susceptibility was proven, or neuromuscular condition suspected, in 277 (21%) patients. Recurrent episodes of rhabdomyolysis, positive family history, and a 50-fold increase or persistently elevated levels of CK raised the possibility of genetic susceptibility. Among those 277 patients, 193 were so identified, in which 72 (37%) were found to have an unequivocal genetic defect among 22 genes, including 56 variants, that explained the increased susceptibility to rhabdomyolysis. With increasing use of next-generation sequencing, it is expected that more genetic defects will be uncovered in the future as being relevant to rhabdomyolysis susceptibility.

    COMMENTARY

    Acute renal failure is a characteristic accompaniment of severe rhabdomyolysis, yet its mechanism of injury remains unclear. Renal tubules and vessels from patients and mice with rhabdomyolysis and acute kidney injury were examined to determine if complement activation played a role. Activation of the lectin complement pathway was found, while the alternative pathway was activated by myoglobin-derived heme, indicating a double-trigger mechanism for complement activation, via both the lectin and alternative pathways. Kidney function was preserved in C3 knock-out mice, supporting a direct pathological role for complement in renal failure associated with rhabdomyolysis. Heme and complement play a direct role in rhabdomyolysis-induced acute kidney injury.1

    REFERENCE

    1. Boudhabhay I, Poillerat V, Grunenwald A, et al. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis. Kidney Int 2020; Oct 30:S0085-2538(20)31244-8. doi: 10.1016/j.kint.2020.09.033. [Online ahead of print].

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 40, No. 5) - January 2021
    January 1, 2021

    Table Of Contents

    Neurotropism of COVID-19: What Is New?

    Cranial Neuropathy in CIDP

    Rapid Eye Movement Sleep Duration Is Predictive of Life Expectancy

    Rhabdomyolysis Etiology

    Medical Therapy vs. Carotid Endarterectomy in Patients with Asymptomatic Carotid Stenosis

    Ticagrelor, a New Antiplatelet Agent, Shows Promise in Secondary Prevention of Ischemic Stroke

    A Mobile Interventional Stroke Team (MIST) Shows Promise in Performing Rapid Thrombectomy

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing